News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,998 Results
Type
Article (41078)
Company Profile (276)
Press Release (666644)
Multimedia
Podcasts (58)
Webinars (12)
Section
Business (206425)
Career Advice (2012)
Deals (35745)
Drug Delivery (97)
Drug Development (82395)
Employer Resources (172)
FDA (16352)
Job Trends (15019)
News (349174)
Policy (32812)
Tag
Academia (2594)
Accelerated approval (5)
Adcomms (23)
Allergies (86)
Alliances (50257)
ALS (96)
Alzheimer's disease (1389)
Antibody-drug conjugate (ADC) (149)
Approvals (16346)
Artificial intelligence (275)
Autoimmune disease (23)
Automation (17)
Bankruptcy (361)
Best Places to Work (11773)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (200)
Bladder cancer (84)
Brain cancer (29)
Breast cancer (300)
Cancer (2416)
Cardiovascular disease (179)
Career advice (1681)
Career pathing (30)
CAR-T (163)
Cell therapy (452)
Cervical cancer (21)
Clinical research (67161)
Collaboration (880)
Company closure (2)
Compensation (576)
Complete response letters (20)
COVID-19 (2603)
CRISPR (43)
C-suite (260)
Cystic fibrosis (102)
Data (2354)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (275)
Diagnostics (6459)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87636)
Editorial (41)
Employer branding (21)
Employer resources (146)
Events (114575)
Executive appointments (751)
FDA (17745)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (778)
Gene editing (112)
Generative AI (24)
Gene therapy (318)
GLP-1 (728)
Government (4459)
Grass and pollen (4)
Guidances (162)
Healthcare (19061)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (131)
Indications (29)
Infectious disease (2749)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (99)
Interviews (312)
IPO (16657)
IRA (41)
Job creations (3661)
Job search strategy (1426)
Kidney cancer (11)
Labor market (43)
Layoffs (493)
Leadership (17)
Legal (7943)
Liver cancer (79)
Lung cancer (342)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (331)
MASH (77)
Medical device (13435)
Medtech (13440)
Mergers & acquisitions (19663)
Metabolic disorders (710)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1951)
NextGen: Class of 2025 (6579)
Non-profit (4515)
Now hiring (40)
Obesity (374)
Opinion (211)
Ovarian cancer (83)
Pain (91)
Pancreatic cancer (89)
Parkinson's disease (155)
Partnered (22)
Patents (247)
Patient recruitment (118)
Peanut (46)
People (58061)
Pharmaceutical (67)
Pharmacy benefit managers (19)
Phase I (20989)
Phase II (29562)
Phase III (22041)
Pipeline (1395)
Policy (148)
Postmarket research (2595)
Preclinical (8898)
Press Release (64)
Prostate cancer (113)
Psychedelics (31)
Radiopharmaceuticals (259)
Rare diseases (387)
Real estate (5968)
Recruiting (65)
Regulatory (22558)
Reports (47)
Research institute (2371)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (74)
Series A (134)
Series B (91)
Service/supplier (11)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3645)
State (2)
Stomach cancer (15)
Supply chain (68)
Tariffs (50)
The Weekly (37)
Vaccines (709)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (176)
Last 7 days (970)
Last 30 days (3240)
Last 365 days (32951)
2025 (12084)
2024 (35677)
2023 (40498)
2022 (51697)
2021 (56234)
2020 (54540)
2019 (47056)
2018 (35458)
2017 (32660)
2016 (32031)
2015 (38067)
2014 (31754)
2013 (26724)
2012 (28929)
2011 (29662)
2010 (27615)
Location
Africa (727)
Alabama (59)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38642)
Australia (6321)
California (6464)
Canada (2069)
China (550)
Colorado (274)
Connecticut (282)
Delaware (158)
Europe (84096)
Florida (958)
Georgia (216)
Idaho (58)
Illinois (558)
India (25)
Indiana (324)
Iowa (11)
Japan (175)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (933)
Massachusetts (4875)
Michigan (226)
Minnesota (409)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1806)
New Mexico (28)
New York (1817)
North Carolina (999)
North Dakota (8)
Northern California (2850)
Ohio (212)
Oklahoma (14)
Oregon (34)
Pennsylvania (1439)
Puerto Rico (13)
Rhode Island (33)
South America (1109)
South Carolina (26)
South Dakota (1)
Southern California (2423)
Tennessee (107)
Texas (958)
United States (24277)
Utah (188)
Virginia (151)
Washington D.C. (65)
Washington State (570)
West Virginia (3)
Wisconsin (57)
707,998 Results for "strata oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
May 9, 2025
·
2 min read
Press Releases
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update
May 8, 2025
·
3 min read
Press Releases
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
March 28, 2025
·
17 min read
Press Releases
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update
March 21, 2025
·
3 min read
Pharm Country
STRATA Skin Sciences to Participate in June 2024 Dermatology Conferences
STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its participation in two dermatology conferences in the month of June.
June 4, 2024
·
4 min read
Business
Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization
Strata Oncology, Inc. (“Strata”), a next-generation precision oncology company enabling smarter cancer treatment, today announced the appointment of Goz Alhir as Senior Vice President, Commercialization.
September 26, 2023
·
2 min read
Business
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024
STRATA Skin Sciences, Inc. announces the placement of six XTRAC® devices with dermatology clinics in the first quarter of 2024 that are considered “comebacks.”
April 30, 2024
·
3 min read
Business
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
STRATA Skin Sciences, Inc. announces its financial results for the quarter ended March 31, 2024 and provides a corporate update.
May 15, 2024
·
14 min read
Pharm Country
STRATA Skin Sciences Sponsors Webinars Featuring Leading Dermatologists Discussing Benefits of XTRAC® and TheraClear®X Devices
STRATA Skin Sciences, Inc. announces the availability of two virtual webinars that discuss the benefits of using its XTRAC® excimer device for the treatment of psoriasis, vitiligo, and eczema and its TheraClear®X photopneumatic device for the treatment of mild to moderate acne.
June 12, 2024
·
5 min read
Business
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
STRATA Skin Sciences, Inc. announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close.
May 8, 2024
·
3 min read
1 of 70,800
Next
